XML 23 R17.htm IDEA: XBRL DOCUMENT
v3.25.1

Fair Value | 3 Months Ended
--- | ---
Mar. 31, 2025
Fair Value [Abstract] |
Fair Value | NOTE 6 - FAIR VALUE Fair value is the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. There are three levels of inputs that may be used to measure fair values: Level 1 – Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. Level 2 – Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3 – Significant unobservable inputs that reflect a company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. The Company used the following methods and significant assumptions to estimate the fair value of each type of asset and liability: Securities available for sale: The fair value of securities available for sale is determined using pricing models that vary based on asset class and include available trade, bid and other market information or matrix pricing, which is a mathematical technique widely used in the industry to value debt securities without relying exclusively on quoted prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted securities (Level 2). Derivatives: The fair value of derivatives, which includes interest rate lock commitments and interest rate swaps, is based on valuation models using observable market data as of the measurement date (Level 2). Loans held for sale: Loans held for sale are carried at fair value, as determined by outstanding commitments from third party investors (Level 2). Assets and liabilities measured at fair value on a recurring basis, including financial assets and liabilities for which the Company has elected the fair value option, are summarized below:
|  | Fair Value Measurements at March 31, 2025 using Significant Other Observable Inputs |
|  | (Level 2) |
|  | (unaudited) |
Financial Assets: |  |  |  |
Securities available for sale: |  |  |  |
Corporate debt |  | $ |  | 7,800 |
Issued by U.S. government-sponsored entities and agencies: |  |  |  |
U.S. Treasury |  |  |  | 993 |
Total securities available for sale |  | $ |  | 8,793 |
Loans held for sale |  | $ |  | 3,505 |
Derivative assets |  | $ |  | 3,352 |
Financial Liabilities: |  |  |  |
Derivative liabilities |  | $ |  | 3,352 |
|  | Fair Value Measurements at December 31, 2024 using Significant Other Observable Inputs |
|  | (Level 2) |
Financial Assets: |  |  |  |
Securities available for sale: |  |  |  |
Corporate debt |  | $ |  | 7,700 |
Issued by U.S. government-sponsored entities and agencies: |  |  |  |
U.S. Treasury |  |  |  | 983 |
Total securities available for sale |  | $ |  | 8,683 |
Loans held for sale |  | $ |  | 2,623 |
Derivative assets |  | $ |  | 3,730 |
Financial Liabilities: |  |  |  |
Derivative liabilities |  | $ |  | 3,730 |
The Company had no assets or liabilities measured at fair value on a recurring basis that were measured using Level 1 or Level 3 inputs at March 31, 2025 or December 31, 2024. There were no transfers of assets or liabilities measured at fair value between levels during the periods ended March 31, 2025 and December 31, 2024. There were no assets or liabilities measured at fair value on a non-recurring basis at March 31, 2025 and December 31, 2024. There were no charge offs on individually evaluated collateral dependent loans during the three months ended March 31, 2025 or 2024. Financial Instruments Recorded Using Fair Value Option The Company has elected the fair value option for loans held for sale. These loans are intended for sale and the Company believes that the fair value is the best indicator of the resolution of these loans. Interest income is recorded based on the contractual terms of the loan and in accordance with the Company’s policy on loans held for investment. No ne of these loans were 90 days or more past due or on nonaccrual as of March 31, 2025 or December 31, 2024. As of March 31, 2025 and December 31, 2024, the aggregate fair value, contractual balance and gain or loss on loans held for sale were as follows:
|  | March 31, 2025 |  |  | December 31, 2024 |
|  | (unaudited) |  |  |  |  |
Aggregate fair value |  | $ |  | 3,505 |  |  | $ |  | 2,623 |
Contractual balance |  |  |  | 3,505 |  |  |  |  | 2,623 |
Gain (loss) |  | $ |  | — |  |  | $ |  | — |
The total amount of gains and losses from changes in fair value included in earnings for the three months ended March 31, 2025 and 2024 for loans held for sale were:
|  | Three months ended March 31, |
|  | 2025 |  |  | 2024 |
|  | (unaudited) |
Interest income |  | $ |  | 35 |  |  | $ |  | 28 |
Interest expense |  |  |  | — |  |  |  |  | — |
Change in fair value |  |  |  | — |  |  |  |  | — |
Total change in fair value |  | $ |  | 35 |  |  | $ |  | 28 |
The carrying amounts and estimated fair values of financial instruments at March 31, 2025 were as follows:
|  | Fair Value Measurements at March 31, 2025 Using: |
|  | Carrying |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(unaudited) |  | Value |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Financial Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ |  | 240,986 |  |  | $ |  | 240,986 |  |  | $ |  | — |  |  | $ |  | — |  |  | $ |  | 240,986 |
Interest-bearing deposits in other financial institutions |  |  |  | 100 |  |  |  |  | 100 |  |  |  |  | — |  |  |  |  | — |  |  |  |  | 100 |
Securities available for sale |  |  |  | 8,793 |  |  |  |  | — |  |  |  |  | 8,793 |  |  |  |  | — |  |  |  |  | 8,793 |
Loans held for sale |  |  |  | 3,505 |  |  |  |  | — |  |  |  |  | 3,505 |  |  |  |  | — |  |  |  |  | 3,505 |
Loans and leases, net |  |  |  | 1,750,139 |  |  |  |  | — |  |  |  |  | — |  |  |  |  | 1,731,307 |  |  |  |  | 1,731,307 |
FHLB and FRB stock |  |  |  | 8,022 |  |  |  | n/a |  |  |  | n/a |  |  |  | n/a |  |  |  | n/a |
Accrued interest receivable |  |  |  | 9,174 |  |  |  |  | 333 |  |  |  |  | 212 |  |  |  |  | 8,629 |  |  |  |  | 9,174 |
Derivative assets |  |  |  | 3,352 |  |  |  |  | — |  |  |  |  | 3,352 |  |  |  |  | — |  |  |  |  | 3,352 |
Financial Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deposits |  | $ |  | (1,783,689 | ) |  | $ |  | (1,076,864 | ) |  | $ |  | (706,759 | ) |  | $ |  | — |  |  | $ |  | (1,783,623 | )
FHLB advances and other borrowings |  |  |  | (92,689 | ) |  |  |  | — |  |  |  |  | (93,735 | ) |  |  |  | — |  |  |  |  | (93,735 | )
Advances by borrowers for taxes and insurance |  |  |  | (1,346 | ) |  |  |  | — |  |  |  |  | — |  |  |  |  | (1,346 | ) |  |  |  | (1,346 | )
Subordinated debentures |  |  |  | (15,009 | ) |  |  |  | — |  |  |  |  | (16,954 | ) |  |  |  | — |  |  |  |  | (16,954 | )
Accrued interest payable |  |  |  | (2,467 | ) |  |  |  | — |  |  |  |  | (2,467 | ) |  |  |  | — |  |  |  |  | (2,467 | )
Derivative liabilities |  |  |  | (3,352 | ) |  |  |  | — |  |  |  |  | (3,352 | ) |  |  |  | — |  |  |  |  | (3,352 | )
The carrying amounts and estimated fair values of financial instruments at December 31, 2024 were as follows:
|  | Fair Value Measurements at December 31, 2024 Using: |
|  | Carrying |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Value |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Financial Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ |  | 235,272 |  |  | $ |  | 235,272 |  |  | $ |  | — |  |  | $ |  | — |  |  | $ |  | 235,272 |
Interest-bearing deposits in other financial institutions |  |  |  | 100 |  |  |  |  | 100 |  |  |  |  | — |  |  |  |  | — |  |  |  |  | 100 |
Securities available for sale |  |  |  | 8,683 |  |  |  |  | — |  |  |  |  | 8,683 |  |  |  |  | — |  |  |  |  | 8,683 |
Equity securities |  |  |  | 5,000 |  |  |  |  | — |  |  |  |  | 5,000 |  |  |  |  | — |  |  |  |  | 5,000 |
Loans held for sale |  |  |  | 2,623 |  |  |  |  | — |  |  |  |  | 2,623 |  |  |  |  | — |  |  |  |  | 2,623 |
Loans and leases, net |  |  |  | 1,722,019 |  |  |  |  | — |  |  |  |  | — |  |  |  |  | 1,691,030 |  |  |  |  | 1,691,030 |
FHLB and FRB stock |  |  |  | 8,918 |  |  |  | n/a |  |  |  | n/a |  |  |  | n/a |  |  |  | n/a |
Accrued interest receivable |  |  |  | 8,395 |  |  |  |  | 182 |  |  |  |  | 151 |  |  |  |  | 8,062 |  |  |  |  | 8,395 |
Derivative assets |  |  |  | 3,730 |  |  |  |  | — |  |  |  |  | 3,730 |  |  |  |  | — |  |  |  |  | 3,730 |
Financial Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deposits |  | $ |  | (1,755,795 | ) |  | $ |  | (1,065,780 | ) |  | $ |  | (689,282 | ) |  | $ |  | — |  |  | $ |  | (1,755,062 | )
FHLB advances and other borrowings |  |  |  | (92,680 | ) |  |  |  | — |  |  |  |  | (94,414 | ) |  |  |  | — |  |  |  |  | (94,414 | )
Advances by borrowers for taxes and insurance |  |  |  | (2,238 | ) |  |  |  | — |  |  |  |  | — |  |  |  |  | (2,238 | ) |  |  |  | (2,238 | )
Subordinated debentures |  |  |  | (15,000 | ) |  |  |  | — |  |  |  |  | (17,021 | ) |  |  |  | — |  |  |  |  | (17,021 | )
Accrued interest payable |  |  |  | (2,259 | ) |  |  |  | — |  |  |  |  | (2,259 | ) |  |  |  | — |  |  |  |  | (2,259 | )
Derivative liabilities |  |  |  | (3,730 | ) |  |  |  | — |  |  |  |  | (3,730 | ) |  |  |  | — |  |  |  |  | (3,730 | )

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 107 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2E -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 940 -SubTopic 820 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration